Ursodeoxycholic Acid Market Size, Trends And Forecast 2031Posted by pooja on August 4th, 2022  Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. Cholestatic liver diseases are at the forefront of driving demand in the global ursodeoxycholic acid market. Rising instances of gall stones and cystic fibrosis is in large part responsible for driving the market. As per 2015 data released by Cystic Fibrosis Foundation, about 30,000 people are afflicted with cystic fibrosis in the U.S. alone. The two types of ursodeoxycholic acid available in the market are extraction ursodeoxycholic acid and synthetic ursodeoxycholic acid. Of the two, the synthetic ursodeoxycholic acid is more substantial. Ursodeoxycholic acid finds usage in health products and pharmacy. Between the two, the health products generate most of the demand. Some of the prominent participants in the global ursodeoxycholic acid market are Arcelor Chemicals, Abil Chempharma, Daewoong Chemical, Biotavia Labs, and Dipharma Francis. Market competition is intense. The overall ursodeoxycholic acid market is highly competitive and with consumer awareness will grow in future. Get Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4221 About TMR Research Contact: Like it? Share it! More by this author |